@article{638ae52ce8554423b907a9e4601e6a78,
title = "Therapeutic efficacy of human monoclonal antibodies against andes virus infection in syrian hamsters",
abstract = "Andes virus, an orthohantavirus endemic to South America, causes severe hantavirus cardiopulmonary syndrome associated with human-to-human transmission. No approved treatments or vaccines against this virus are available. We show that a combined treatment with 2 monoclonal antibodies protected Syrian hamsters when administered at midstage or late-stage disease.",
author = "Williamson, {Brandi N.} and Joseph Prescott and Garrido, {Jose L.} and Alvarez, {Raymond A.} and Heinz Feldmann and Barr{\'i}a, {Maria I.}",
note = "Funding Information: This work was partially funded by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health. M.I.B. was partially supported by the National Agency for Research and Development/FONDEF (ID14I20084) in collaboration with Ichor Biologics. J.L.G. and R.A. were partially supported by a Small Business Innovation Research grant through the NIAID (grant R43 AI138740-01A1). Publisher Copyright: {\textcopyright} 2021 Centers for Disease Control and Prevention (CDC). All rights reserved.",
year = "2021",
month = oct,
doi = "10.3201/eid2710.210735",
language = "English",
volume = "27",
pages = "2707--2710",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "10",
}